Psyomics develops Censeo, a digital diagnostic support platform that mirrors the depth of a comprehensive face-to-face mental health assessment through adaptive questions and an auto-generated report of potential conditions and next-step recommendations. The platform is designed to guide individual users through a stigma-free assessment and to support clinicians (including non-psychiatrists) in establishing appropriate care pathways more quickly. The company ran a pilot within GP practices that received positive feedback from both GPs and patients, and it recently opened access to individual users while starting new projects within NHS treatment providers. Psyomics was spun out from the University of Cambridge and is co-founded by Professor Sabine Bahn and Daniel Cowell. The company raised funding to continue expanding access to Censeo among individual users and NHS trusts. Psyomics has developed Censeo, a digital mental-health assessment and diagnosis platform built on 20 years of clinical research. Censeo mirrors the process of a face-to-face psychiatric assessment by guiding patients through adaptive questions while algorithms generate a bespoke ‘map’ of an individual’s mental health and provide diagnosis where appropriate. The platform is intended to help GPs and clinicians provide the right level of support earlier, give patients a less confrontational start to care, and relieve strain on the healthcare system. Psyomics says Censeo is ready to hit the UK market and has been developed as a medical device compliant with the Medical Device Directive 93/42 EEC, ISO 13485 and the NHS Toolkit. The company has closed a £1.5 million funding round to commercialize the platform, and prior funding came from Cambridge Enterprise, Innovate UK, Parkwalk and the European Commission’s Horizon 2020 programme. Co-founder and Chief Medical Officer Prof. Sabine Bahn highlights long diagnostic delays for conditions such as depression and bipolar disorder, underscoring the need for improved diagnostic tools.

Total raised

$5M

Funding rounds

2

Latest round

Series B

Latest activity

Jun 2022